252 related articles for article (PubMed ID: 26814638)
1. Membrane Interactions, Ligand-Dependent Dynamics, and Stability of Cytochrome P4503A4 in Lipid Nanodiscs.
Treuheit NA; Redhair M; Kwon H; McClary WD; Guttman M; Sumida JP; Atkins WM
Biochemistry; 2016 Feb; 55(7):1058-69. PubMed ID: 26814638
[TBL] [Abstract][Full Text] [Related]
2. Membrane Fluidity Modulates Thermal Stability and Ligand Binding of Cytochrome P4503A4 in Lipid Nanodiscs.
McClary WD; Sumida JP; Scian M; Paço L; Atkins WM
Biochemistry; 2016 Nov; 55(45):6258-6268. PubMed ID: 27782404
[TBL] [Abstract][Full Text] [Related]
3. Dynamics and Location of the Allosteric Midazolam Site in Cytochrome P4503A4 in Lipid Nanodiscs.
Redhair M; Hackett JC; Pelletier RD; Atkins WM
Biochemistry; 2020 Feb; 59(6):766-779. PubMed ID: 31961139
[TBL] [Abstract][Full Text] [Related]
4. Conformational transitions in the membrane scaffold protein of phospholipid bilayer nanodiscs.
Morgan CR; Hebling CM; Rand KD; Stafford DW; Jorgenson JW; Engen JR
Mol Cell Proteomics; 2011 Sep; 10(9):M111.010876. PubMed ID: 21715319
[TBL] [Abstract][Full Text] [Related]
5. Ligand binding to cytochrome P450 3A4 in phospholipid bilayer nanodiscs: the effect of model membranes.
Nath A; Grinkova YV; Sligar SG; Atkins WM
J Biol Chem; 2007 Sep; 282(39):28309-28320. PubMed ID: 17573349
[TBL] [Abstract][Full Text] [Related]
6. Nanodisc-embedded cytochrome P450 P3A4 binds diverse ligands by distributing conformational dynamics to its flexible elements.
Paço L; Hackett JC; Atkins WM
J Inorg Biochem; 2023 Jul; 244():112211. PubMed ID: 37080138
[TBL] [Abstract][Full Text] [Related]
7. Small-angle scattering determination of the shape and localization of human cytochrome P450 embedded in a phospholipid nanodisc environment.
Skar-Gislinge N; Kynde SA; Denisov IG; Ye X; Lenov I; Sligar SG; Arleth L
Acta Crystallogr D Biol Crystallogr; 2015 Dec; 71(Pt 12):2412-21. PubMed ID: 26627649
[TBL] [Abstract][Full Text] [Related]
8. Flexible structure of cytochrome P450: promiscuity of ligand binding in the CYP3A4 heme pocket.
Ohkura K; Kawaguchi Y; Watanabe Y; Masubuchi Y; Shinohara Y; Hori H
Anticancer Res; 2009 Mar; 29(3):935-42. PubMed ID: 19414330
[TBL] [Abstract][Full Text] [Related]
9. Probing possible egress channels for multiple ligands in human CYP3A4: a molecular modeling study.
Krishnamoorthy N; Gajendrarao P; Thangapandian S; Lee Y; Lee KW
J Mol Model; 2010 Apr; 16(4):607-14. PubMed ID: 19727863
[TBL] [Abstract][Full Text] [Related]
10. Isotropic bicelles stabilize the juxtamembrane region of the influenza M2 protein for solution NMR studies.
Claridge JK; Aittoniemi J; Cooper DM; Schnell JR
Biochemistry; 2013 Nov; 52(47):8420-9. PubMed ID: 24168642
[TBL] [Abstract][Full Text] [Related]
11. Versatile applicability of a grid-based CYP3A4 Template to understand the interacting mechanisms with the small-size ligands; part 3 of CYP3A4 Template study.
Yamazoe Y; Goto T; Tohkin M
Drug Metab Pharmacokinet; 2020 Jun; 35(3):253-265. PubMed ID: 32331852
[TBL] [Abstract][Full Text] [Related]
12. Comparative EPR studies on lipid bilayer properties in nanodiscs and liposomes.
Stepien P; Polit A; Wisniewska-Becker A
Biochim Biophys Acta; 2015 Jan; 1848(1 Pt A):60-6. PubMed ID: 25306967
[TBL] [Abstract][Full Text] [Related]
13. Formation of size-controlled, denaturation-resistant lipid nanodiscs by an amphiphilic self-polymerizing peptide.
Kondo H; Ikeda K; Nakano M
Colloids Surf B Biointerfaces; 2016 Oct; 146():423-30. PubMed ID: 27393815
[TBL] [Abstract][Full Text] [Related]
14. Drug-drug interation prediction between ketoconazole and anti-liver cancer drug Gomisin G.
Xiaoyang L; Chenming N; Chengqing L; Tao L
Afr Health Sci; 2015 Jun; 15(2):590-3. PubMed ID: 26124807
[TBL] [Abstract][Full Text] [Related]
15. Incorporation of charged residues in the CYP2J2 F-G loop disrupts CYP2J2-lipid bilayer interactions.
McDougle DR; Baylon JL; Meling DD; Kambalyal A; Grinkova YV; Hammernik J; Tajkhorshid E; Das A
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt A):2460-2470. PubMed ID: 26232558
[TBL] [Abstract][Full Text] [Related]
16. Membrane-embedded substrate recognition by cytochrome P450 3A4.
Hackett JC
J Biol Chem; 2018 Mar; 293(11):4037-4046. PubMed ID: 29382727
[TBL] [Abstract][Full Text] [Related]
17. Structure and mechanism of the complex between cytochrome P4503A4 and ritonavir.
Sevrioukova IF; Poulos TL
Proc Natl Acad Sci U S A; 2010 Oct; 107(43):18422-7. PubMed ID: 20937904
[TBL] [Abstract][Full Text] [Related]
18. Behavior of human cytochromes P450 on lipid membranes.
Berka K; Paloncýová M; Anzenbacher P; Otyepka M
J Phys Chem B; 2013 Oct; 117(39):11556-64. PubMed ID: 23987570
[TBL] [Abstract][Full Text] [Related]
19. Cytochrome P450 3A4 inhibition by ketoconazole: tackling the problem of ligand cooperativity using molecular dynamics simulations and free-energy calculations.
Bren U; Oostenbrink C
J Chem Inf Model; 2012 Jun; 52(6):1573-82. PubMed ID: 22587011
[TBL] [Abstract][Full Text] [Related]
20. Computational Investigation of Ligand Binding to the Peripheral Site in CYP3A4: Conformational Dynamics and Inhibitor Discovery.
Du H; Li J; Cai Y; Zhang H; Liu G; Tang Y; Li W
J Chem Inf Model; 2017 Mar; 57(3):616-626. PubMed ID: 28221037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
